• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国广东2010年手足口病流行期前后肠道病毒71型和柯萨奇病毒A16型的血清流行率

Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period.

作者信息

Li Wei, Yi Lina, Su Juan, Lu Jing, Ke Changwen, Zeng Hanri, Guan Dawei, Ma Cong, Zhang Wanly, Xiao Hong, Li Hui, Lin Jinyan, Zhang Yonghui

机构信息

Center of Pathogen Detection Research for Emerging Infectious Diseases, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China ; Key Laboratory of Pathogen Detection for Emergency Response, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China ; Key Laboratory of Depository and Application for Pathogenic Microbiology, Guangdong Provincial Centre for Disease Control and Prevention, Guangzhou, China.

出版信息

PLoS One. 2013 Dec 4;8(12):e80515. doi: 10.1371/journal.pone.0080515. eCollection 2013.

DOI:10.1371/journal.pone.0080515
PMID:24324604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3850913/
Abstract

BACKGROUND

Human Enterovirus 71 and Coxsackie A16 have caused many outbreaks in the last decade in mainland China, resulting in thousands of fatal cases. Seroepidemiology which provides important information to document population immunity is rare in China.

METHODOLOGY/PRINCIPAL FINDINGS: A cross sectional study of Enterovirus 71 (EV71) and Coxsackie A16 (CA16) seroprevalence was carried out in Guangdong, China, pre- and post- the 2010 hand, foot and mouth disease (HFMD) epidemic period. The levels of EV71 and CA16 specific antibodies were evaluated by a microneutralization test and the geometric mean titer (GMT) was calculated and compared. Our results indicated frequent infection by EV71 and CA16 in Guangdong before the 2010 epidemic. Only EV71 neutralizing antibody but not CA16 seroprevalence was significantly increased after the 2010 HFMD epidemic. Children less than 3 years old especially those aged 2 years showed the lowest positive rates for EV71 and CA16 NA before epidemic and the most significantly increased EV71 seroprevalence after epidemic. CA16 GMT values declined after the 2010 epidemic.

CONCLUSIONS

These results indicate EV71 was the major pathogen of HFMD in Guangdong during the 2010 epidemic. The infection occurs largely in children less than 3 years, who should have first priority to receive an EV71 vaccine.

摘要

背景

在过去十年中,肠道病毒71型(Human Enterovirus 71,EV71)和柯萨奇病毒A16型(Coxsackie A16,CA16)在中国内地引发了多次疫情,导致数千例死亡病例。血清流行病学研究可为了解人群免疫力提供重要信息,但在中国此类研究较少。

方法/主要发现:在中国广东,于2010年手足口病(hand, foot and mouth disease,HFMD)流行期前后开展了一项关于EV71和CA16血清流行率的横断面研究。通过微量中和试验评估EV71和CA16特异性抗体水平,并计算和比较几何平均滴度(geometric mean titer,GMT)。我们的结果表明,在2010年疫情之前,广东地区EV71和CA16感染较为频繁。2010年手足口病疫情后,仅EV71中和抗体而非CA16血清流行率显著上升。3岁以下儿童,尤其是2岁儿童,在疫情前EV71和CA16中和抗体阳性率最低,疫情后EV71血清流行率上升最为显著。2010年疫情后CA16的GMT值下降。

结论

这些结果表明,EV71是2010年广东手足口病的主要病原体。感染主要发生在3岁以下儿童中,这些儿童应优先接种EV71疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/19d0b6d75442/pone.0080515.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/d7bece12dc88/pone.0080515.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/0ef13a8d74c2/pone.0080515.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/7510c1d3c5aa/pone.0080515.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/19d0b6d75442/pone.0080515.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/d7bece12dc88/pone.0080515.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/0ef13a8d74c2/pone.0080515.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/7510c1d3c5aa/pone.0080515.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e0c/3850913/19d0b6d75442/pone.0080515.g004.jpg

相似文献

1
Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period.中国广东2010年手足口病流行期前后肠道病毒71型和柯萨奇病毒A16型的血清流行率
PLoS One. 2013 Dec 4;8(12):e80515. doi: 10.1371/journal.pone.0080515. eCollection 2013.
2
Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China.中国广东省儿童中人类肠道病毒 71 型和柯萨奇病毒 A16 的血清流行病学研究。
BMC Infect Dis. 2013 Jul 15;13:322. doi: 10.1186/1471-2334-13-322.
3
Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.泰国东北部不同年龄人群中肠道病毒 71 型和柯萨奇病毒 A16 型抗体的血清流行率。
Virol J. 2018 Oct 16;15(1):158. doi: 10.1186/s12985-018-1074-8.
4
Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.手足口病:德国柯萨奇 A16 和肠道病毒 71 的血清流行率。
Med Microbiol Immunol. 2010 Feb;199(1):45-51. doi: 10.1007/s00430-009-0133-6. Epub 2009 Nov 26.
5
[Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].[2002年上海手足口病患儿肠道病毒71型和柯萨奇病毒A16型的检测]
Zhonghua Er Ke Za Zhi. 2005 Sep;43(9):648-52.
6
Epidemiology Characteristics of Human Coxsackievirus A16 and Enterovirus 71 Circulating in Linyi, China, from 2009 to 2017.2009年至2017年中国临沂地区人肠道柯萨奇病毒A16型和肠道病毒71型的流行病学特征
Jpn J Infect Dis. 2018 Nov 22;71(6):470-473. doi: 10.7883/yoken.JJID.2018.035. Epub 2018 Jun 29.
7
Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016.2012-2016 年中国上海手足口病的流行病学和血清学监测。
Emerg Microbes Infect. 2018 Jan 24;7(1):8. doi: 10.1038/s41426-017-0011-z.
8
Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16.2009年至2010年上海市手足口病流行特征:肠道病毒71型C4亚型为主要病原体,与柯萨奇病毒A16混合感染发生率高。
Scand J Infect Dis. 2012 Apr;44(4):297-305. doi: 10.3109/00365548.2011.634433. Epub 2011 Dec 18.
9
The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.人用和兽用肠道病毒71型灭活疫苗与柯萨奇病毒A16型和脊髓灰质炎病毒疫苗的兼容性。
Hum Vaccin Immunother. 2015;11(11):2723-33. doi: 10.1080/21645515.2015.1011975. Epub 2015 Feb 25.
10
A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.一种新型肠道病毒71型灭活疫苗可在小鼠体内引发针对柯萨奇病毒A16的交叉保护性免疫。
Vaccine. 2016 Nov 21;34(48):5938-5945. doi: 10.1016/j.vaccine.2016.10.018. Epub 2016 Oct 19.

引用本文的文献

1
Seroprevalence of Enterovirus 71 Among Children in Western India.印度西部儿童肠道病毒71型血清阳性率
Viruses. 2025 Feb 28;17(3):356. doi: 10.3390/v17030356.
2
Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019-2021.2019 - 2021年中国广州肠道病毒A71型血清流行率
Biosaf Health. 2023 May 6;5(3):168-173. doi: 10.1016/j.bsheal.2023.05.002. eCollection 2023 Jun.
3
Seroprevalence of coxsackievirus A6 and enterovirus A71 infection in humans: a systematic review and meta-analysis.柯萨奇病毒 A6 和肠道病毒 A71 感染在人类中的血清流行率:系统评价和荟萃分析。

本文引用的文献

1
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial.新型肠道病毒 71 型灭活疫苗的免疫原性、安全性和免疫持久性:一项 II 期、随机、双盲、安慰剂对照试验。
J Infect Dis. 2014 Jan 1;209(1):46-55. doi: 10.1093/infdis/jit429. Epub 2013 Aug 6.
2
Progress on the research and development of inactivated EV71 whole-virus vaccines.肠道病毒 71 型灭活全病毒疫苗的研究与开发进展。
Hum Vaccin Immunother. 2013 Aug;9(8):1701-5. doi: 10.4161/hv.24949. Epub 2013 Jun 6.
3
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Arch Virol. 2023 Jan 7;168(2):37. doi: 10.1007/s00705-022-05642-0.
4
Effect of difference between EV-A71 virus epidemic strain and "vaccine strain" on neutralizing antibody titer.肠道病毒 71 型流行株与“疫苗株”差异对中和抗体效价的影响。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2121565. doi: 10.1080/21645515.2022.2121565. Epub 2022 Sep 16.
5
Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis.不同年龄组人群中柯萨奇病毒A16抗体的血清流行率:一项系统评价和荟萃分析
Arch Public Health. 2021 Sep 17;79(1):166. doi: 10.1186/s13690-021-00688-z.
6
Molecular surveillance of coxsackievirus A16 in southern China, 2008-2019.中国南方柯萨奇病毒 A16 的分子监测,2008-2019 年。
Arch Virol. 2021 Jun;166(6):1653-1659. doi: 10.1007/s00705-021-05052-8. Epub 2021 Apr 1.
7
Tracking echovirus eleven outbreaks in Guangdong, China: a metatranscriptomic, phylogenetic, and epidemiological study.追踪中国广东肠道病毒11型疫情:一项宏转录组学、系统发育学和流行病学研究。
Virus Evol. 2020 May 10;6(1):veaa029. doi: 10.1093/ve/veaa029. eCollection 2020 Jan.
8
Process optimization for the rapid production of Enterovirus 71.肠道病毒71型快速生产的工艺优化
Cytotechnology. 2019 Dec;71(6):1053-1061. doi: 10.1007/s10616-019-00340-3. Epub 2019 Sep 26.
9
Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.泰国东北部不同年龄人群中肠道病毒 71 型和柯萨奇病毒 A16 型抗体的血清流行率。
Virol J. 2018 Oct 16;15(1):158. doi: 10.1186/s12985-018-1074-8.
10
Severity and burden of hand, foot and mouth disease in Asia: a modelling study.亚洲手足口病的严重程度和负担:一项建模研究。
BMJ Glob Health. 2018 Jan 26;3(1):e000442. doi: 10.1136/bmjgh-2017-000442. eCollection 2018.
在中国儿童中使用灭活铝佐剂肠道病毒 71 型疫苗的疗效、安全性和免疫学研究:一项多中心、随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2013 Jun 8;381(9882):2024-32. doi: 10.1016/S0140-6736(13)61049-1. Epub 2013 May 29.
4
Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China.中国广东省手足口病时空聚集性及其危险因素分析。
PLoS One. 2013;8(2):e56943. doi: 10.1371/journal.pone.0056943. Epub 2013 Feb 21.
5
Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China.中国江苏省人肠道病毒 71 型和柯萨奇病毒 A16 血清流行病学研究。
Virol J. 2012 Oct 29;9:248. doi: 10.1186/1743-422X-9-248.
6
Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009.2009年中国河南省手足口病疫情中肠道病毒71型和柯萨奇病毒A16型的检测
Virus Genes. 2013 Feb;46(1):1-9. doi: 10.1007/s11262-012-0814-x. Epub 2012 Oct 19.
7
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.EV71 灭活疫苗免疫原性和保护效果的比较分析。
PLoS One. 2012;7(9):e46043. doi: 10.1371/journal.pone.0046043. Epub 2012 Sep 28.
8
Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010.中国大陆 1998-2010 年人类肠道病毒 71 型 C4 株的种群动态和遗传多样性。
PLoS One. 2012;7(9):e44386. doi: 10.1371/journal.pone.0044386. Epub 2012 Sep 12.
9
Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases.广州市手足口病病原学及流行病学分析:4753 例病例回顾
Braz J Infect Dis. 2012 Sep-Oct;16(5):457-65. doi: 10.1016/j.bjid.2012.08.001. Epub 2012 Sep 7.
10
Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys.中国广东 2009 年大流行流感后甲型 H1N1 病毒血清流行率的时间趋势:三项横断面血清学调查。
PLoS One. 2012;7(6):e38768. doi: 10.1371/journal.pone.0038768. Epub 2012 Jun 18.